Hertfordshire, United Kingdom

Ann Jacqueline Hunter

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 8(Granted Patents)


Location History:

  • Stevenage, GB (2015)
  • Hertfordshire, GB (2017)

Company Filing History:


Years Active: 2015-2017

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Ann Jacqueline Hunter: Innovator in Pharmaceutical Combinations

Introduction

Ann Jacqueline Hunter is a notable inventor based in Hertfordshire, GB. She has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic combinations. With a total of two patents to her name, her work is recognized for its potential impact on medical treatments.

Latest Patents

Hunter's latest patents include innovative combinations comprising 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline. This combination involves the use of 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline or a pharmaceutically acceptable salt thereof, paired with a second therapeutic agent. The second therapeutic agent is selected from various options, showcasing the versatility of her inventions. Additionally, her patents explore the use of this compound for the treatment of various conditions, highlighting its therapeutic potential.

Career Highlights

Ann Jacqueline Hunter is currently associated with Axovant Sciences GmbH, where she continues to advance her research and development efforts. Her work at this company emphasizes her commitment to improving healthcare through innovative solutions.

Collaborations

Hunter collaborates with esteemed colleagues, including Tsu Tshen Chuang and David John Virley. These partnerships enhance her research capabilities and contribute to the success of her projects.

Conclusion

Ann Jacqueline Hunter's contributions to pharmaceutical innovations demonstrate her expertise and dedication to improving medical treatments. Her patents reflect a promising future in the field of therapeutics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…